Sweroside
CAS: 14215-86-2
Ref. 3D-FS73846
10mg | 183,00 € | ||
25mg | 329,00 € | ||
50mg | 469,00 € | ||
100mg | 760,00 € | ||
250mg | 1.430,00 € |
Produktinformation
- (4aS,5R,6S)-5-Ethenyl-6-(β-<span class="text-smallcaps">D</span>-glucopyranosyloxy)-4,4a,5,6-tetrahydro-1H,3H-pyrano[3,4-c]pyran-1-one
- (4aS,5R,6S)-5-Ethenyl-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,4a,5,6-tetrahydro-3H-pyrano[3,4-c]pyran-1-one
- (4aS,5R,6S)-5-ethenyl-1-oxo-4,4a,5,6-tetrahydro-1H,3H-pyrano[3,4-c]pyran-6-yl beta-D-glucopyranoside
- 1H,3H-Pyrano[3,4-c]pyran-1-one, 5-ethenyl-6-(β-<span class="text-smallcaps">D</span>-glucopyranosyloxy)-4,4a,5,6-tetrahydro-, (4aS,5R,6S)-
- 1H,3H-Pyrano[3,4-c]pyran-1-one, 5-ethenyl-6-(β-<span class="text-smallcaps">D</span>-glucopyranosyloxy)-4,4a,5,6-tetrahydro-, [4aS-(4aα,5β,6α)]-
Sweroside is a natural compound that belongs to the family of bioactive phenolic compounds. It has been shown to have anti-inflammatory and genotoxic activities. Sweroside also inhibits the production of serotonin in the brain and thereby prevents the onset of ischemia-reperfusion injury. In addition, sweroside has been found to be effective in treating myocardial infarct in rats and inhibiting 5-HT2 receptors. Sweroside can be detected using an analytical method involving HPLC with preparative hplc, human serum, or human osteosarcoma cells as a receptor. The active form of sweroside is loganic acid, which can be isolated from the fructus of Swerria erythrocarpa var. pendula (L.) Seem.
Chemische Eigenschaften
Technische Anfrage zu: 3D-FS73846 Sweroside
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.